<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04558658</url>
  </required_header>
  <id_info>
    <org_study_id>N/L ratio in IBD activity</org_study_id>
    <nct_id>NCT04558658</nct_id>
  </id_info>
  <brief_title>Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease</brief_title>
  <official_title>Evaluation of Neutrophil to Lymphocyte Ratio in Inflammatory Bowel Disease in Assiut University Hospitals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Detection of Inflammatory Bowel Disease activity by Using new measure : Neutrophil to&#xD;
      lymphocyte ratio&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inflammatory bowel disease (IBD) has been a global healthcare problem with a sustained&#xD;
      increasing incidence. It includes two major forms, Crohn's disease (CD) and ulcerative&#xD;
      colitis (UC), which are distinct chronic bowel-relapsing inflammatory disorders (Gharagozloo&#xD;
      et al., 2015). Ulcerative colitis (UC) is limitd to Mucosa and cause continuous bowel&#xD;
      inflammation (Celikbilek et al., 2013) While Crohn disease is more complex because of its&#xD;
      transmural inflammation and it is characterized by skip lesions, which are diseased sections&#xD;
      of bowel next to uninvolved areas(Nishijima David L; Wisner, David H; Holmes, James F, 2016).&#xD;
      The prevalence of IBD is highest in the second to third decade of life with another peak in&#xD;
      the 60-70- year-old group.(Silva et al., 2016) Non-invasive tests, such as C reactive protein&#xD;
      (CRP), erythrocyte sedimentation rate (ESR) and white blood cells (WBC) are therefore being&#xD;
      increasingly recognized as important markers for initial diagnosis and disease activity&#xD;
      detection.(Gao et al., 2015) In recent years, the neutrophil-to-lymphocyte ratio (NLR),&#xD;
      calculated as total neutrophil count divided by total lymphocyte count, NLR represents two&#xD;
      different immune pathways and can be easily derived directly from a standard blood&#xD;
      test..(Argeny et al., 2018)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Neutrophil to lymphocyte ratio in IBD</measure>
    <time_frame>baseline</time_frame>
    <description>Determination of the prognostic value of N/L ratio in patients with IBD as a non invasive measure of disease acitivity</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Complete Blood Count</intervention_name>
    <description>neutrophil to lymphocyte ratio</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed IBD by endoscopy, clinical , biochemical correlation and&#xD;
        histopathological biopsy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with inflammatory bowel disease, diagnosed by endoscopy, clinical ,&#xD;
             biochemical correlation and histopathological biopsy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients have :&#xD;
&#xD;
          -  Appendicitis&#xD;
&#xD;
          -  sigmoid diverticular disease&#xD;
&#xD;
          -  Infectious colitis&#xD;
&#xD;
          -  patients known to have cancer colon&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed Khaled</last_name>
    <phone>01005897058</phone>
    <email>ak0555012@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wael Abbas</last_name>
    <phone>01064236064</phone>
    <email>Drwaelabbas@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Argeny S, Stift A, Bergmann M, Mittlböck M, Maschke S, Yang Y, Chitsabesan P, Riss S. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn's disease. Wien Klin Wochenschr. 2018 Jun;130(11-12):398-403. doi: 10.1007/s00508-018-1322-3. Epub 2018 Feb 12.</citation>
    <PMID>29435759</PMID>
  </reference>
  <reference>
    <citation>Celikbilek M, Dogan S, Ozbakır O, Zararsız G, Kücük H, Gürsoy S, Yurci A, Güven K, Yücesoy M. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal. 2013 Jan;27(1):72-6. doi: 10.1002/jcla.21564. Epub 2013 Jan 4.</citation>
    <PMID>23292894</PMID>
  </reference>
  <reference>
    <citation>Gao SQ, Huang LD, Dai RJ, Chen DD, Hu WJ, Shan YF. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity. Int J Clin Exp Pathol. 2015 Nov 1;8(11):14779-85. eCollection 2015.</citation>
    <PMID>26823804</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>September 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Khaled Mohammed</investigator_full_name>
    <investigator_title>Evaluation of neutrophil-to-lymphocyte ratio in inflammatory bowel disease in assuit university hospitals</investigator_title>
  </responsible_party>
  <keyword>neutrophil to lymphocyte ratio</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

